循环E1/CDK2激活定义了在妇科癌症中对WEE1激酶抑制的关键脆弱性
Daehwan Kim1, Heekyung Chung1, Wen Liu1
1Zentalis Pharmaceuticals, Inc., San Diego, CA, USA.
NPJ precision oncology
|January 4, 2025
概括
高环素E1表达预测了在妇科癌症中对WEE1抑制剂阿泽诺谢蒂布的敏感性. 在细胞系和动物模型中观察到的这一发现支持正在进行的卵巢和子宫血清性癌的临床试验.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 环素E1/CDK2激活通过加速细胞循环驱动妇科癌症.
- WEE1激酶是细胞循环进展的负调节剂,抵消环林E1/CDK2.
- 针对WEE1为患有循环E1/CDK2失调的癌症提供了潜在的治疗策略.
研究的目的:
- 研究Cyclin E1/CDK2激活与对WEE1抑制剂azenosertib的敏感性之间的关系.
- 在妇科恶性瘤的临床前模型中评估azenosertib的疗效.
- 评估阿泽诺谢蒂布作为单一疗法或与化疗结合使用的潜力.
主要方法:
- 在妇科癌细胞系中表达Cyclin E1水平的表征.
- 在体外和体内对阿泽诺谢蒂布敏感性的评估.
- 对复制应激标志物和细胞对阿泽诺塞蒂布的反应进行评估.
- 与各种化疗剂的组合研究.
- 从I期研究中分析早期临床数据.
主要成果:
- 高内源性或过度表达的Cyclin E1在卵巢癌细胞系中对阿泽诺谢蒂布产生了极好的敏感性.
- 这种敏感性在卵巢和子宫血清癌的临床前模型中得到证实.
- 具有高Cyclin E1的模型表现出基线复制应激增加和对azenosertib的增强反应.
- 阿泽诺谢尔蒂布与多种化疗类别显示出协同作用.
- 早期I期数据表明,在相关患者群体中,阿泽诺谢蒂布单一治疗的临床活性.
结论:
- 环素E1表达水平是妇科癌症中阿泽诺塞蒂布敏感性的预测生物标志物.
- 阿泽诺瑟蒂布是治疗Cyclin E1/CDK2-激活卵巢和子宫血清癌的一个有前途的治疗药物.
- 需要对单独或联合使用的阿泽诺谢蒂布进行进一步的临床研究.
更多相关视频
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
27.1K
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
14.2K
相关概念视频
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
M-Cdk Drives Transition Into Mitosis
5.4K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.4K
Positive Regulator Molecules
5.2K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.2K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Negative Regulator Molecules
35.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.0K
